These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
436 related items for PubMed ID: 28387984
41. Eculizumab in the treatment of atypical haemolytic uraemic syndrome and other complement-mediated renal diseases. Nester CM, Brophy PD. Curr Opin Pediatr; 2013 Apr; 25(2):225-31. PubMed ID: 23486421 [Abstract] [Full Text] [Related]
43. Success of eculizumab in the treatment of atypical hemolytic uremic syndrome. Baskin E, Gulleroglu K, Kantar A, Bayrakci U, Ozkaya O. Pediatr Nephrol; 2015 May; 30(5):783-9. PubMed ID: 25384530 [Abstract] [Full Text] [Related]
45. Eculizumab: a review of its use in atypical haemolytic uraemic syndrome. Keating GM. Drugs; 2013 Dec; 73(18):2053-66. PubMed ID: 24249647 [Abstract] [Full Text] [Related]
47. Eculizumab discontinuation in children and adults with atypical hemolytic-uremic syndrome: a prospective multicenter study. Fakhouri F, Fila M, Hummel A, Ribes D, Sellier-Leclerc AL, Ville S, Pouteil-Noble C, Coindre JP, Le Quintrec M, Rondeau E, Boyer O, Provôt F, Djeddi D, Hanf W, Delmas Y, Louillet F, Lahoche A, Favre G, Châtelet V, Launay EA, Presne C, Zaloszyc A, Caillard S, Bally S, Raimbourg Q, Tricot L, Mousson C, Le Thuaut A, Loirat C, Frémeaux-Bacchi V. Blood; 2021 May 06; 137(18):2438-2449. PubMed ID: 33270832 [Abstract] [Full Text] [Related]
48. Consensus opinion on diagnosis and management of thrombotic microangiopathy in Australia and New Zealand. Fox LC, Cohney SJ, Kausman JY, Shortt J, Hughes PD, Wood EM, Isbel NM, de Malmanche T, Durkan A, Hissaria P, Blombery P, Barbour TD. Nephrology (Carlton); 2018 Jun 06; 23(6):507-517. PubMed ID: 29419916 [Abstract] [Full Text] [Related]
50. Atypical haemolytic uraemic syndrome in the eculizumab era: presentation, response to treatment and evaluation of an eculizumab withdrawal strategy. Neave L, Gale DP, Cheesman S, Shah R, Scully M. Br J Haematol; 2019 Jul 06; 186(1):113-124. PubMed ID: 30916388 [Abstract] [Full Text] [Related]
55. [Atypical hemolytic uremic syndrome in an elderly patient successfully treated with eculizumab]. Fukasawa C, Ooishi S, Kumagai T, Koshiisi M, Sueki Y, Nakajima K, Mitsumori T, Yoshida Y, Kato H, Nangaku M, Miyata T, Kirito K. Rinsho Ketsueki; 2018 May 06; 59(2):182-186. PubMed ID: 29515071 [Abstract] [Full Text] [Related]
59. Efficacy and safety of eculizumab in childhood atypical hemolytic uremic syndrome in Japan. Ito N, Hataya H, Saida K, Amano Y, Hidaka Y, Motoyoshi Y, Ohta T, Yoshida Y, Terano C, Iwasa T, Kubota W, Takada H, Hara T, Fujimura Y, Ito S. Clin Exp Nephrol; 2016 Apr 06; 20(2):265-72. PubMed ID: 26156042 [Abstract] [Full Text] [Related]
60. Complement functional tests for monitoring eculizumab treatment in patients with atypical hemolytic uremic syndrome: an update. Ardissino G, Tel F, Sgarbanti M, Cresseri D, Giussani A, Griffini S, Grovetto E, Possenti I, Perrone M, Testa S, Paglialonga F, Messa P, Cugno M. Pediatr Nephrol; 2018 Mar 06; 33(3):457-461. PubMed ID: 29046944 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]